Clinical Research Directory
Browse clinical research sites, groups, and studies.
Regulatory Post-Marketing Surveillance Study for Brolucizumab
Sponsor: Novartis Pharmaceuticals
Summary
This study is an open-label, multicenter, single-arm, observational post-marketing surveillance.
Official title: Regulatory Post-Marketing Surveillance (rPMS) Study for Brolucizumab(Beovu ® Injection, Beovu ®Prefilled Syringe)
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
OBSERVATIONAL
Enrollment
3000
Start Date
2021-08-18
Completion Date
2026-06-14
Last Updated
2025-01-14
Healthy Volunteers
No
Interventions
brolucizumab
Prospective observational study. There is no treatment allocation. Patients administered brolucizumab, that have started before inclusion of the patient into the study will be enrolled.
Locations (28)
Novartis Investigative Site
Daegu, Dalseo Gu, South Korea
Novartis Investigative Site
Goyang-si, Gyeonggi-do, South Korea
Novartis Investigative Site
Guri-si, Gyeonggi-do, South Korea
Novartis Investigative Site
Suwon, Gyeonggi-do, South Korea
Novartis Investigative Site
Iksan Si, Jeonlabuk Do, South Korea
Novartis Investigative Site
Daejeon, Korea, South Korea
Novartis Investigative Site
Busan, South Korea
Novartis Investigative Site
Busan, South Korea
Novartis Investigative Site
Busan, South Korea
Novartis Investigative Site
Daegu, South Korea
Novartis Investigative Site
Daegu, South Korea
Novartis Investigative Site
Gwangju, South Korea
Novartis Investigative Site
Gwangju, South Korea
Novartis Investigative Site
Incheon, South Korea
Novartis Investigative Site
Jeju City, South Korea
Novartis Investigative Site
Pusan, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Seoul, South Korea
Novartis Investigative Site
Taegu, South Korea